Today's Date: March 29, 2024
Amerex Group Unveils Red Carter Swimwear's Revitalized Collection   •   Coachella Concerned That People Have Sex, Says AHF   •   National University Receives 2024 Military Friendly® Gold Designation   •   Jamieson Wellness Publishes Inaugural Sustainability Impact Report   •   Taro Pharmaceuticals U.S.A., Inc. Expands OTC Portfolio for Children with the Introduction of bébé Bottoms™   •   Equalpride Partners with TransLash Media for Trans Day of Visibility, Amplifying Voices of Black Trans Femmes in the Arts   •   Make-A-Wish and celebrity wish granters announce goal to recruit 1 million people to become "WishMakers"   •   Carnegie Learning Named 2024 SIIA CODiE Award Finalist for Best Educational Game and Best AI Implementation in Ed Tech   •   Midea Group releases its first-ever ESG brand story with an unexpected VIP visit highlighting its commitment to sustainability.   •   Parkland Corporation Announces the Results of the 2024 Annual General Meeting of Shareholders   •   Sypher Secures Strategic Partnership with FAIA to Fuel Growth   •   Anaergia Announces Escrow Closing of Second Tranche of the Strategic Investment   •   Suffolk Kicks off 2024 “Build With Us @ Suffolk” Program in Boston for Trade Partners, Opening Doors for Minority-,   •   Re:wild and Colossal Biosciences team up to leverage revolutionary technology to save critically endangered species on the brink   •   Anaergia Announces Delay in the Filing of Its Audited Financial Statements and Related Disclosures   •   VIRGIN HOTELS CHAMPIONS INCLUSIVE TRAVEL FOR NEURODIVERSE TRAVELERS   •   Visit Visalia Recognizes Autism Awareness Month in April   •   Empire State Realty Trust Receives WELL Health-Safety Leadership Award; Becomes Among the First Commercial Office and Multifamil   •   YMCA of the USA Partners With Old Spice To Increase High School Graduation Among Boys And Young Men Of Color Through Mentorship   •   Fosun Management on 2023 Annual Results: Focusing on Core Industries with Established Advantages
Bookmark and Share

Perfuze Announces Appointment of New Chair of the Board

GALWAY, Ireland , June 09 /Businesswire/ - Perfuze, a medical device company developing next-generation "super-bore" catheter technology to treat acute ischemic stroke, is pleased to announce the appointment of Hooman Hakami as the new Chair of the Board. This appointment reflects Perfuze's commitment to bring devices to market that have the potential to transform the treatment of acute ischemic stroke. Hooman brings a wealth of experience and expertise to Perfuze, making him an invaluable addition to the company's leadership team. With an impressive track record in the medical device industry, Hooman has held prominent leadership positions within Medtronic and GE Healthcare, driving innovation, growth, and profitability.

As the new Chair of the Board, Hooman will play a pivotal role in guiding Perfuze's strategic direction and spearheading the company's mission to transform the treatment landscape for acute ischemic stroke. His previous Board experience and strategic insights will be instrumental in supporting the advance of Perfuze's groundbreaking technologies and therapies, ultimately improving patient outcomes. "I am honored to join Perfuze as the Chair of the Board," said Hooman. "Perfuze's commitment to developing innovative solutions for stroke aligns perfectly with my enthusiasm for advancing medical technologies that have the potential to significantly impact patients' lives. I am joining at an exciting time in the company’s development, as we move towards enrolling our first patient in our upcoming pivotal US IDE clinical study. I look forward to collaborating closely with the talented team at Perfuze to achieve our shared vision."

Perfuze's CEO, Wayne Allen, expressed his enthusiasm about the appointment, stating, "We are delighted to welcome Hooman to Perfuze. His exceptional leadership qualities and extensive industry experience will undoubtedly strengthen our board and accelerate our journey towards redefining stroke treatment. We believe that Hooman's guidance will be invaluable as we continue to push the boundaries of medical innovation."

About Perfuze

Based in Galway, Ireland, Perfuze is a dynamic medical device company that has developed super-bore diameter aspiration technology that is designed to navigate complex neurovascular anatomy. The company’s pipeline of products is designed to facilitate fast, complete clot removal following acute ischemic stroke. Perfuze is committed to continuing its research and development efforts to advance the field of neurovascular care and aims to provide neurointerventional physicians with advanced tools to restore blood flow, minimize brain damage, and improve patient outcomes.

For more information, please visit www.perfuze.com


STORY TAGS: Personnel, Medical Devices, Health, Ireland, Europe,

Video

White House Live Stream
LIVE VIDEO EVERY SATURDAY
alsharpton Rev. Al Sharpton
9 to 11 am EST
jjackson Rev. Jesse Jackson
10 to noon CST


Video

LIVE BROADCASTS
Sounds Make the News ®
WAOK-Urban
Atlanta - WAOK-Urban
KPFA-Progressive
Berkley / San Francisco - KPFA-Progressive
WVON-Urban
Chicago - WVON-Urban
KJLH - Urban
Los Angeles - KJLH - Urban
WKDM-Mandarin Chinese
New York - WKDM-Mandarin Chinese
WADO-Spanish
New York - WADO-Spanish
WBAI - Progressive
New York - WBAI - Progressive
WOL-Urban
Washington - WOL-Urban

Listen to United Natiosns News